BRL-26830A is a beta-adrenergic receptor agonist. BRL-26830A reduces body weight and increases metabolic rate in obese mouse models. BRL-26830A stimulates insulin release and significantly reduces blood glucose levels in ICR mouse models. BRL-26830A can be used to study endocrine and metabolic diseases such as obesity and diabetes[1][2][2].
Molecular Weight:
371.45
CAS Number:
[87857-42-9]
Formula:
C19H23NO3.1/2C4H4O4
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
